New Drug Keeps Common Breast Cancer Under Control Longer: Study
Adding Ibrance to standard hormone therapy kept disease from progressing for nine months
Source: HealthDay
Related MedlinePlus Pages: Breast Cancer, Medicines
Source: MedlinePlus Health News - Category: Consumer Health News Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Health | Hormonal Therapy | Hormones | Study